Longitudinal reductions in distinct cortical regions may serve as an ideal metric for differentiating NMOSD from MS and may provide evidence of subclinical disease activity.
Okuda et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: